Will Nintedanib be reimbursed by medical insurance? What is the price of Nintedanib?

Nintedanib (Nintedanib) The original drug is marketed in China as nintedanib ethanesulfonate soft capsules and has entered the scope of Class B medical insurance. However, reimbursement is limited to patients who meet the indications, including idiopathic pulmonary fibrosis (IPF) or systemic sclerosis-related interstitium. For patients with chronic lung disease (SSc-ILD), SpecificationsThe price of 150mg*30 capsules per box may be more than 4,000 yuan. The reimbursement ratio is different in different regions, and the price after reimbursement may be different. Please consult the local medical insurance bureau or hospital for details.

These lung volume benefits were seen primarily in the usual interstitial pneumonia (UIP) pattern and systemic sclerosis-associated interstitial lung disease when nintedanib was given in combination with mycophenolate mofetil or cyclophosphamide. There are also benefits to using it when other treatments are contraindicated. Improved patient outcomes led to the approval of nintedanib by the U.S. Food and Drug Administration (FDA) in 2020 for progressive fibrotic ILD and SSc ILD. Similar improvements in lung volume have been described in patients with bleomycin-induced fibrosis and COVID-19-related pulmonary fibrosis.

Nintedanib Original drug available overseas has Turkish version and Indian version, specificationsThe price of 150mg*60 capsules per box may be more than 5,000 RMB (the price may fluctuate due to the exchange rate). There are also nintedanib generic drugs produced overseas in other countries. For example, the price of 150mg*30 capsules produced by BDR Pharmaceutical Factory in India may be several hundred yuan per box (the price may fluctuate due to exchange rates). Its pharmaceutical ingredients are basically the same as those of the original drugs sold domestically and abroad.